Related Experiment Videos
[Occult intrapulmonary hemorrhage caused by anticoagulants]
Summary
Intrapulmonary occult bleeding, a rare anticoagulant complication, presents as respiratory distress and diffuse lung imaging. Diagnosis involves identifying alveolar siderophages via bronchoalveolar lavage.
Area of Science:
- Pulmonology
- Hematology
- Internal Medicine
Background:
- Anticoagulant therapy is crucial for preventing thrombotic events.
- Intrapulmonary occult bleeding is a rare but serious complication of anticoagulation.
- Diagnosis is challenging due to its infrequent reporting and subtle presentation.
Observation:
- Two cases of severe hemorrhagic syndrome (melaena, epistaxis) and laboratory abnormalities (Hb <9 g/dL, PT <10%) occurred during oral anticoagulant therapy.
- Patients developed acute respiratory distress syndrome (ARDS) within 24-48 hours, characterized by dyspnea, hypoxia/hypercapnia, and diffuse micronodular/miliary X-ray findings.
- Bronchoalveolar lavage (BAL) revealed numerous alveolar siderophages, confirming intrapulmonary bleeding.
Findings:
- Intrapulmonary occult bleeding can manifest as ARDS in patients on anticoagulants.
- BAL is diagnostic but may transiently worsen hypoxia, requiring careful consideration.
- The presence of alveolar siderophages is a key diagnostic indicator.
Implications:
- Clinicians should consider intrapulmonary occult bleeding in patients with anticoagulant imbalance and unexplained respiratory distress with specific radiological findings.
- Early recognition and appropriate management are vital for patient outcomes.
- This highlights the importance of a multidisciplinary approach in managing complex anticoagulant-related complications.